Bank of America Merrill Lynch is out with its report today on Albemarle ALB, downgrading ALB to Underperform from Buy.
In its report, Bank of America Merrill Lynch writes, "Our rating moves to Underperform from Buy. Our
constructive thesis has been predicated on two pillars: ongoing strength in catalysts and earnings growth in the bromine chain fueled by price increases and cyclical volume recovery. The latter is now at greater risk in our view in the event of a recession, now seen as a 35% probability by BofAML's economics team."
Bank of America Merrill Lynch has a $65 PO on ALB.
Shares of ALB closed Tuesday at $56.03, up 8.88% from Monday's close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Analyst ColorDowngradesAnalyst RatingsBank of America Merrill LynchMaterialsSpecialty Chemicals
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in